V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160872 | 20062079 | 1.6 | 64.5 | Adjuvant (A) | 2016-07-07 | 2016-07-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101411460 |
| 20160874 | 20062080 | 1.57 | 49.5 | Adjuvant (A) | 2016-08-21 | 2016-08-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100157626 |
| 20160875 | 20062081 | 1.48 | 93 | Palliative (P) | 2017-07-26 | 2017-07-26 | ECX | 02 | N | ECX | 100052130 |
| 20160876 | 20062082 | 1.78 | 92.9 | Adjuvant (A) | 2018-12-29 | 2019-01-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101697932 |
| 20160877 | 20062083 | 1.54 | 51 | Neo-adjuvant (N) | 2016-08-27 | 2016-09-08 | ECX | 02 | N | ECX | 101055651 |
| 20160878 | 20062084 | 1.68 | 80.4 | Palliative (P) | 2020-04-01 | 2020-04-21 | ECX | N | N | ECX | 101552801 |
| 20160879 | 20062085 | 1.64 | 53.55 | null | 2019-09-21 | 2019-10-03 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101277780 |
| 20160882 | 20062086 | 1.88 | 66.7 | Curative (C) | 2018-06-08 | 2018-06-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101686871 |
| 20160883 | 20062087 | 1.65 | 102.2 | Disease modification (D) | 2017-11-07 | 2017-11-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100452510 |
| 20160885 | 20062088 | 1.51 | 57.4 | Adjuvant (A) | 2018-05-25 | 2018-06-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101381265 |
| 20160887 | 20062089 | 1.74 | 54.9 | Adjuvant (A) | 2016-11-22 | 2016-12-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101681370 |
| 20160888 | 20062090 | 1.5 | 93.7 | Palliative (P) | 2016-08-10 | 2016-09-07 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100395261 |
| 20160889 | 20062091 | 1.63 | 117.8 | Neo-adjuvant (N) | 2020-01-07 | 2020-01-17 | ECX | 2 | N | ECX | 101591721 |
| 20160890 | 20062092 | null | null | Neo-adjuvant (N) | 2019-01-02 | 2019-01-02 | ECX | 02 | N | ECX | 100037965 |
| 20160891 | 20062093 | 1.67 | 45.95 | Neo-adjuvant (N) | null | 2017-01-30 | ECX | N | N | ECX | 100691162 |
| 20160892 | 20062094 | 1.71 | 61.4 | Palliative (P) | 2016-12-02 | 2016-12-06 | ECX | N | N | ECX | 100369403 |
| 20160893 | 20062095 | 1.62 | 75.6 | Palliative (P) | 2019-08-28 | 2019-09-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101531101 |
| 20160894 | 20062096 | 1.6 | 117 | Adjuvant (A) | 2017-01-05 | 2017-01-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101321311 |
| 20160897 | 20062097 | 1.62 | 74.9 | Adjuvant (A) | 2016-12-25 | 2017-01-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100032376 |
| 20160898 | 20062098 | 1.74 | 54.9 | Palliative (P) | 2016-11-24 | 2016-12-02 | ECX | N | null | ECX | 101499216 |
| 20160899 | 20062099 | null | 85.5 | Palliative (P) | 2018-05-15 | 2018-05-29 | ECX | N | N | ECX | 101067752 |
| 20160900 | 20062100 | 1.54 | 83.6 | Curative (C) | 2017-05-20 | 2017-06-08 | ECX | N | N | ECX | 100921318 |
| 20160902 | 20062101 | 1.5 | 97 | Palliative (P) | 2020-01-31 | 2020-02-15 | ECX | N | N | ECX | 101447528 |
| 20160903 | 20062102 | 1.86 | 51.7 | Palliative (P) | 2018-06-15 | 2018-06-23 | ECX | N | N | ECX | 101868388 |
| 20160904 | 20062103 | 1.6 | 59.9 | Neo-adjuvant (N) | 2017-09-18 | 2017-10-02 | ECX | 2 | N | ECX | 100745358 |
| 20160905 | 20062104 | 1.67 | 58 | Palliative (P) | 2019-09-10 | 2019-09-18 | ECX | N | N | ECX | 101452067 |
| 20160906 | 20062105 | 1.67 | 71.5 | Adjuvant (A) | 2017-05-20 | 2017-05-20 | ECX | N | N | ECX | 100485271 |
| 20160907 | 20062106 | 1.83 | 78 | Neo-adjuvant (N) | 2019-02-17 | 2019-03-09 | ECX | 02 | N | ECX | 100888322 |
| 20160910 | 20062107 | 1.75 | 128 | Adjuvant (A) | 2019-01-21 | 2019-01-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100600859 |
| 20160912 | 20062108 | 1.86 | 53 | Adjuvant (A) | 2019-11-29 | 2019-12-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100090682 |
| 20160913 | 20062109 | 1.7 | 88 | Neo-adjuvant (N) | 2018-06-23 | 2018-07-11 | ECX | 02 | Y | ECX | 101567777 |
| 20160914 | 20062110 | 1.78 | 96 | Palliative (P) | 2019-03-07 | 2019-03-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100236644 |
| 20160917 | 20062111 | 1.82 | 65.75 | null | 2018-10-20 | 2018-10-28 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101201952 |
| 20160918 | 20062112 | 1.69 | 61 | Neo-adjuvant (N) | 2019-10-06 | 2019-10-12 | ECX | N | N | ECX | 101350494 |
| 20160920 | 20062113 | 1.54 | 85 | Palliative (P) | 2016-05-31 | 2016-06-12 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101679077 |
| 20160921 | 20062114 | 1.69 | 91 | Neo-adjuvant (N) | 2018-02-02 | 2018-02-18 | ECX | N | N | ECX | 100461761 |
| 20160923 | 20062115 | 1.72 | 50 | Adjuvant (A) | 2019-06-23 | 2019-06-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101007700 |
| 20160924 | 20062116 | 1.52 | 68.25 | Adjuvant (A) | 2016-01-31 | 2016-02-12 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100792115 |
| 20160926 | 20062117 | 1.59 | 69.5 | Palliative (P) | 2018-10-12 | 2018-10-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100450108 |
| 20160927 | 20062118 | 1.68 | 54 | Palliative (P) | 2018-12-23 | 2018-12-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101265337 |
| 20160928 | 20062119 | 1.66 | 77 | Neo-adjuvant (N) | 2019-02-24 | 2019-03-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101775434 |
| 20160930 | 20062120 | 1.57 | 83.7 | Neo-adjuvant (N) | 2017-03-14 | 2017-04-02 | ECX | N | N | ECX | 100606262 |
| 20160931 | 20062121 | 1.52 | 61.7 | Curative (C) | 2017-11-21 | 2017-12-03 | ECX | N | null | ECX | 100767561 |
| 20160932 | 20062122 | 1.73 | 81 | Neo-adjuvant (N) | 2019-04-30 | 2019-05-18 | ECX | N | N | ECX | 101783190 |
| 20160933 | 20062123 | null | null | Adjuvant (A) | 2016-07-18 | 2016-07-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100776683 |
| 20160935 | 20062124 | 1.67 | 88 | Palliative (P) | 2018-08-01 | 2018-08-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101718839 |
| 20160936 | 20062125 | 1.57 | 140 | Adjuvant (A) | 2017-10-15 | 2017-10-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100448203 |
| 20160937 | 20062126 | 1.73 | 69.1 | Neo-adjuvant (N) | 2017-08-25 | 2017-09-08 | ECX | 02 | N | ECX | 101068350 |
| 20160938 | 20062127 | 1.56 | 70 | Palliative (P) | 2018-06-12 | 2018-06-23 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100557141 |
| 20160939 | 20062128 | 1.69 | 97.7 | Adjuvant (A) | 2016-12-30 | 2016-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100374878 |